Figure 1From: Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityTime course of patient treatment and therapeutic drug monitoring results. Time course of (A) voriconazole i. v. dosage administration, (B) comedication with esomeprazole or ranitidine and (C) associated antiretroviral therapy. Voriconazole plasma trough concentrations. qd: once a day; b.i.d.: Twice a day.Back to article page